| Dr Edward Cooney, MD | |
|
110 Lone Oak Ln, Hartford, WI 53027-2600 | |
| (262) 670-1800 | |
| (262) 836-1601 |
| Full Name | Dr Edward Cooney |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 110 Lone Oak Ln, Hartford, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235271958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 31932-20 (Wisconsin) | Primary |
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms that complement the Company's world-class portfolio of devices for lower extremity peripheral artery disease.
Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects.
Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step back to move forward.
A new implantable sensor device provides a less-invasive alternative for monitoring pressure within the skull (intracranial pressure, or ICP), suggests a pilot study in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 7 days ago
| Entity Name | Rae Holdings Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922574417 PECOS PAC ID: 6002141900 Enrollment ID: O20190917002939 |
News Archive
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms that complement the Company's world-class portfolio of devices for lower extremity peripheral artery disease.
Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects.
Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step back to move forward.
A new implantable sensor device provides a less-invasive alternative for monitoring pressure within the skull (intracranial pressure, or ICP), suggests a pilot study in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Cooney, MD 110 Lone Oak Ln, Hartford, WI 53027-2600 Ph: (262) 670-1800 | Dr Edward Cooney, MD 110 Lone Oak Ln, Hartford, WI 53027-2600 Ph: (262) 670-1800 |
News Archive
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms that complement the Company's world-class portfolio of devices for lower extremity peripheral artery disease.
Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects.
Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step back to move forward.
A new implantable sensor device provides a less-invasive alternative for monitoring pressure within the skull (intracranial pressure, or ICP), suggests a pilot study in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 7 days ago
Dr. Adnan Zaidi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1640 E Sumner St, Hartford, WI 53027 Phone: 262-670-4000 | |
David Chen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1640 E Sumner St, Hartford, WI 53027 Phone: 262-670-4000 Fax: 262-670-4451 | |
Joseph R Pfotenhauer, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1640 E Sumner St, Hartford, WI 53027 Phone: 262-670-4000 Fax: 262-670-4451 | |
Nadia B Huq, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1640 E Sumner St, Hartford, WI 53027 Phone: 262-670-4000 |